BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5521943)

  • 21. Clinical evaluation of side effects of current oral contraceptives.
    Nelson JH
    J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
    [No Abstract]   [Full Text] [Related]  

  • 22. [Birth control methods in psychiatry].
    Audebert A; Emperaire JC; Cohen J; Bourgeois M
    Ann Med Psychol (Paris); 1974 Jun; 2(1):92-127. PubMed ID: 4447290
    [No Abstract]   [Full Text] [Related]  

  • 23. Fertility control with norethindrone enanthate, a long-acting parenteral progestogen.
    Kesserü-Koós E; Larrañaga-Legufa A; Hurtado-Koo H; Scharff HJ
    Acta Eur Fertil; 1973 Dec; 4(4):203-21. PubMed ID: 4802108
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contraceptives. Side effects and risks].
    García-Conti F
    Rev Colomb Obstet Ginecol; 1971; 22(6):393-407. PubMed ID: 4947668
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biochemical and steroidal indicators in the use of Monogest, a progesterone contraceptive].
    Kobilková J; Zizkovská E; Trnka V
    Cesk Gynekol; 1981 Aug; 46(7):540-1. PubMed ID: 7285177
    [No Abstract]   [Full Text] [Related]  

  • 26. The length of the first three menstrual cycles after combined oral contraceptive treatment.
    Larsson-Cohn U
    Acta Obstet Gynecol Scand; 1969; 48(3):416-22. PubMed ID: 5370780
    [No Abstract]   [Full Text] [Related]  

  • 27. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    Fraser IS; Weisberg E
    Med J Aust; 1981 Jan; 1(SP1):3-19. PubMed ID: 6453269
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term study of a progestational micropill: 600 mcg norethisterone acetate].
    Robey-Lelièvre F; Ruet C
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3):485-97. PubMed ID: 681702
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral anticonception. Side effects and risks.
    Ostergaard E
    Acta Obstet Gynecol Scand; 1969; 48(S1):57-72. PubMed ID: 4244680
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 31. Ortho 1557-O. A new oral contraceptive.
    Ledger WJ
    Int J Fertil; 1970; 15(2):88-92. PubMed ID: 5430391
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
    Wamsteker EF
    Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with the "Minipill"].
    Meng M
    Schweiz Rundsch Med Prax; 1972 Apr; 61(16):519-31. PubMed ID: 5021822
    [No Abstract]   [Full Text] [Related]  

  • 34. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term evaluation of two oral contraceptives.
    Hutcherson WP; Schwartz HA; Weathers W; McGuire JE
    Fertil Steril; 1967; 18(5):616-31. PubMed ID: 6037450
    [No Abstract]   [Full Text] [Related]  

  • 36. A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives.
    Preston SN
    Contraception; 1972 Jul; 6(1):17-35. PubMed ID: 4659582
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
    Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
    Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in hormonal contraception.
    Swyer GI
    Practitioner; 1973 Oct; 211(264):535-40. PubMed ID: 4591772
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral contraceptives during immediate postabortal period.
    Niswonger JW; London GD; Anderson GV; Wolfe L
    Obstet Gynecol; 1968 Sep; 32(3):325-7. PubMed ID: 5742114
    [No Abstract]   [Full Text] [Related]  

  • 40. [No more griseofulvin for pill users: another clinically important interaction?].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1579-80. PubMed ID: 6483028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.